Correlation Between Pfizer and Aquila Narragansett
Can any of the company-specific risk be diversified away by investing in both Pfizer and Aquila Narragansett at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Aquila Narragansett into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Aquila Narragansett Tax Free, you can compare the effects of market volatilities on Pfizer and Aquila Narragansett and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Aquila Narragansett. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Aquila Narragansett.
Diversification Opportunities for Pfizer and Aquila Narragansett
-0.45 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Pfizer and Aquila is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Aquila Narragansett Tax Free in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aquila Narragansett Tax and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Aquila Narragansett. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aquila Narragansett Tax has no effect on the direction of Pfizer i.e., Pfizer and Aquila Narragansett go up and down completely randomly.
Pair Corralation between Pfizer and Aquila Narragansett
Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the Aquila Narragansett. In addition to that, Pfizer is 7.7 times more volatile than Aquila Narragansett Tax Free. It trades about -0.08 of its total potential returns per unit of risk. Aquila Narragansett Tax Free is currently generating about 0.03 per unit of volatility. If you would invest 981.00 in Aquila Narragansett Tax Free on September 13, 2024 and sell it today you would earn a total of 24.00 from holding Aquila Narragansett Tax Free or generate 2.45% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 79.6% |
| Values | Daily Returns |
Pfizer Inc vs. Aquila Narragansett Tax Free
Performance |
| Timeline |
| Pfizer Inc |
| Aquila Narragansett Tax |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Pfizer and Aquila Narragansett Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pfizer and Aquila Narragansett
The main advantage of trading using opposite Pfizer and Aquila Narragansett positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Aquila Narragansett can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aquila Narragansett will offset losses from the drop in Aquila Narragansett's long position.| Pfizer vs. AbbVie Inc | Pfizer vs. Merck Company | Pfizer vs. Eli Lilly and | Pfizer vs. Bristol Myers Squibb |
| Aquila Narragansett vs. Ab Value Fund | Aquila Narragansett vs. Aam Select Income | Aquila Narragansett vs. Scharf Global Opportunity | Aquila Narragansett vs. Falcon Focus Scv |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |